Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Amini Harandi

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Respiratory Medicine|March 15, 2008
An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patientsMostafa Ghanei, Henry D Tazelaar, Marco Chilosi, et al.
Scientific Reports|January 16, 2024
A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigueAli Amini Harandi, Hossein Pakdaman, Aida Medghalchi, et al.
Current Aging Science|February 27, 2023
A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up StudyHossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Cutaneous and Ocular Toxicology|November 30, 2011
Pathogenesis and treatment of skin lesions caused by sulfur mustardZohreh Poursaleh, Mostafa Ghanei, Farhang Babamahmoodi, et al.
Neuroimmunomodulation|August 18, 2022
Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple SclerosisAli Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 16, 2015
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled TrialHossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, et al.
The International Journal of Neuroscience|June 10, 2016
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in IranHossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
BMC Neurology|September 10, 2022
Evaluation of the epidemiologic, clinical, radiologic, and treatment methods of patients with subacute and chronic meningitisNiloufar Bineshfar, Ali Rezaei, Alireza Mirahmadi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 13, 2016
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in IranHossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, et al.
Journal of the Neurological Sciences|December 1, 2022
SARS-CoV-2 infection might be a predictor of mortality in intracerebral hemorrhageAshkan Mowla, Banafsheh Shakibajahromi, Shima Shahjouei, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|March 15, 2008
An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patientsMostafa Ghanei, Henry D Tazelaar, Marco Chilosi, et al.
Scientific Reports|January 16, 2024
A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigueAli Amini Harandi, Hossein Pakdaman, Aida Medghalchi, et al.
Current Aging Science|February 27, 2023
A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up StudyHossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Cutaneous and Ocular Toxicology|November 30, 2011
Pathogenesis and treatment of skin lesions caused by sulfur mustardZohreh Poursaleh, Mostafa Ghanei, Farhang Babamahmoodi, et al.
Neuroimmunomodulation|August 18, 2022
Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple SclerosisAli Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 16, 2015
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled TrialHossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, et al.
The International Journal of Neuroscience|June 10, 2016
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in IranHossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
BMC Neurology|September 10, 2022
Evaluation of the epidemiologic, clinical, radiologic, and treatment methods of patients with subacute and chronic meningitisNiloufar Bineshfar, Ali Rezaei, Alireza Mirahmadi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 13, 2016
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in IranHossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, et al.
Journal of the Neurological Sciences|December 1, 2022
SARS-CoV-2 infection might be a predictor of mortality in intracerebral hemorrhageAshkan Mowla, Banafsheh Shakibajahromi, Shima Shahjouei, et al.
Pageof 8